Summary
Rem3dy Health has raised £14 million to accelerate global expansion and AI innovation, valuing the company at £84m. The funding round was led by a group of global strategic investors, including Suntory, Estrella Galicia, Apollo Hospitals and UPSA.
Summary of transaction details:
- Value: £14 million
- Sector: Healthcare & Biotech
- Advisor: Not disclosed
- Key Entities: Rem3dy Health, Suntory, Estrella Galicia, Apollo Hospitals and UPSA
- Location: Midlands, UK
Note: The funding will support Rem3dy Health's rapid growth, which includes expansion into key international markets such as the United States, MENA region, and India, as well as continued investment in automation, advanced manufacturing, and AI-driven personalised nutrition.
Lead Investor / Acquirer
Suntory
Lead Investor / Acquirer
Estrella Galicia
Lead Investor / Acquirer
Apollo Hospitals
Lead Investor / Acquirer
UPSA
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
View the original press release or news article describing this transaction in full.
Read Original PostAI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in